Multi-targeted tyrosine kinase inhibitors in clinical development:Focus on XL-184 (cabozantinib)

Abstract

This research paper explore the methodology and findings associated with Drugs of today. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).